Bausch Historical Income Statement
BHC Stock | USD 8.60 0.06 0.69% |
Historical analysis of Bausch Health income statement accounts such as Interest Expense of 1.4 B, Selling General Administrative of 3.1 B or Total Revenue of 9.2 B can show how well Bausch Health Companies performed in making a profits. Evaluating Bausch Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bausch Health's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Bausch Health Companies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bausch Health Companies is a good buy for the upcoming year.
Bausch |
About Bausch Income Statement Analysis
Bausch Health Companies Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bausch Health shareholders. The income statement also shows Bausch investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Bausch Health Income Statement Chart
Bausch Health Companies Income Statement is one of the three primary financial statements used for reporting Bausch's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Bausch Health Companies revenue and expense. Bausch Health Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Bausch Health's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 9.2 B, whereas Depreciation And Amortization is forecasted to decline to about 871.5 M. Add Fundamental
Total Revenue
Total revenue comprises all receipts Bausch Health Companies generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Bausch Health Companies minus its cost of goods sold. It is profit before Bausch Health operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Bausch Health Companies. It is also known as Bausch Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Bausch Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bausch Health Companies current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. At present, Bausch Health's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 9.2 B, whereas Depreciation And Amortization is forecasted to decline to about 871.5 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 6.0B | 5.8B | 6.2B | 6.5B | Total Revenue | 8.4B | 8.1B | 8.8B | 9.2B |
Bausch Health income statement Correlations
Click cells to compare fundamentals
Bausch Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bausch Health income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 1.9B | 1.8B | 1.4B | 1.2B | 1.3B | 871.5M | |
Interest Expense | 1.6B | 1.5B | 1.4B | 1.5B | 1.3B | 1.4B | |
Selling General Administrative | 2.0B | 1.9B | 2.1B | 2.1B | 2.9B | 3.1B | |
Total Revenue | 8.6B | 8.0B | 8.4B | 8.1B | 8.8B | 9.2B | |
Gross Profit | 6.3B | 5.8B | 6.0B | 5.8B | 6.2B | 6.5B | |
Other Operating Expenses | 8.7B | 6.7B | 7.2B | 6.8B | 7.2B | 7.5B | |
Operating Income | (73M) | 676M | 1.2B | 1.4B | 963M | 1.0B | |
Ebit | (73M) | 676M | 1.2B | 1.4B | 1.6B | 1.7B | |
Ebitda | 3.2B | 1.8B | 2.5B | 2.6B | 2.9B | 1.6B | |
Cost Of Revenue | 2.4B | 2.2B | 2.4B | 2.4B | 2.6B | 2.7B | |
Total Operating Expenses | 6.3B | 4.5B | 4.8B | 4.4B | 4.6B | 4.8B | |
Income Before Tax | (1.8B) | (934M) | (1.0B) | (129M) | (390M) | (409.5M) | |
Total Other Income Expense Net | (1.8B) | (1.6B) | (2.2B) | (1.5B) | (688M) | (722.4M) | |
Net Income | (1.8B) | (559M) | (937M) | (212M) | (592M) | (562.4M) | |
Income Tax Expense | (54M) | (375M) | (87M) | 83M | 221M | 232.1M | |
Research Development | 471M | 452M | 465M | 529M | 604M | 634.2M | |
Net Income Applicable To Common Shares | (1.8B) | (560M) | (948M) | (225M) | (202.5M) | (212.6M) | |
Net Income From Continuing Ops | (1.8B) | (559M) | (937M) | (212M) | (611M) | (641.6M) | |
Non Recurring | 106M | 136M | 234M | 15M | 13.5M | 12.8M | |
Non Operating Income Net Other | (22M) | (76M) | (48M) | 881M | 1.0B | 1.1B | |
Tax Provision | (54M) | (375M) | (87M) | 83M | 221M | 232.1M | |
Net Interest Income | (1.6B) | (1.5B) | (1.4B) | (1.5B) | (1.3B) | (1.4B) | |
Reconciled Depreciation | 2.1B | 1.8B | 1.4B | 1.2B | 1.3B | 1.5B |
Pair Trading with Bausch Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.Moving together with Bausch Stock
0.76 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
0.7 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
Moving against Bausch Stock
0.76 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
0.75 | DRUG | Bright Minds Biosciences | PairCorr |
0.69 | DMTK | DermTech Financial Report 2nd of May 2024 | PairCorr |
0.68 | VCYT | Veracyte Financial Report 2nd of May 2024 | PairCorr |
0.67 | ME | 23Andme Holding | PairCorr |
The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Bausch Stock analysis
When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Bausch Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.115 | Earnings Share (1.62) | Revenue Per Share 23.998 | Quarterly Revenue Growth 0.098 | Return On Assets 0.0382 |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.